Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains

Author:

Mori Mattia1ORCID,Kovalenko Lesia23,Malancona Savina4,Saladini Francesco5ORCID,De Forni Davide6,Pires Manuel2,Humbert Nicolas2,Real Eleonore2,Botzanowski Thomas7,Cianférani Sarah7ORCID,Giannini Alessia5,Dasso Lang Maria Chiara1,Cugia Giulia6,Poddesu Barbara6,Lori Franco6,Zazzi Maurizio5,Harper Steven4,Summa Vincenzo4,Mely Yves2ORCID,Botta Maurizio18ORCID

Affiliation:

1. Department of Biotechnology, Chemistry and Pharmacy, University of Siena, via Aldo Moro 2, 53100 Siena, Italy

2. Laboratoire de Biophotonique et Pharmacologie, UMR 7213, Faculté de Pharmacie, Université de Strasbourg, CNRS, 74 Route du Rhin, 67401 Illkirch, France

3. Department of Chemistry, Kyiv National Taras Shevchenko University, 01033 Kyiv, Ukraine

4. IRBM Science Park S.p.A., Via Pontina Km 30.600, 00071 Pomezia (RM), Italy

5. Department of Medical Biotechnologies, University of Siena, Viale Mario Bracci, 16, 50100 Siena, Italy

6. ViroStatics S.r.l, Viale Umberto I 46, 07100 Sassari, Italy

7. Laboratoire de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France

8. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, BioLife Science Bldg., Suite 333, 1900 N 12th Street, Philadelphia, Pennsylvania 19122, United States

Funder

FP7 Health

Publisher

American Chemical Society (ACS)

Subject

Molecular Medicine,General Medicine,Biochemistry

Reference103 articles.

1. http://www.unaids.org(accessed on October 2017) .

2. Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?

3. http://www.who.Int/HIV/topics/drugresistance/hivresnet/en(accessed on October 2017) .

4. Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3